| Sandoz Pharmaceuticals AG - Co-Irbesartan Sandoz 150/12,5 mg, Filmtabletten | | 62640 | | 01 | | Co-Irbesartan Sandoz 150/12,5 mg | | Filmtabletten | | C09DA04 | | Irbesartan und Diuretika | | 06.11.2012 | | |
| | Composition | | irbesartanum 150 mg, hydrochlorothiazidum 12.5 mg, cellulosum microcristallinum, lactosum monohydricum 8 mg, carmellosum natricum conexum corresp. natrium 0.595 mg, silica colloidalis anhydrica, hypromellosum, cellulosum microcristallinum silicificatum, magnesii stearas, Überzug: hypromellosum, hydroxypropylcellulosum, macrogolum 6000, lactosum monohydricum 0.252 mg, talcum, E 171, E 172 (rubrum), E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Hydrochlorothiazide | 12.5 mg | | Irbesartan | 150 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Hydrochlorothiazide | 12.5 mg | | Irbesartan | 150 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | (Rubrum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | Cellulosum Microcristallinum Silicificatum | | | | E 171 | | color. | | E 172 | | color. | | Hydroxypropylcellulosum | | | | Hypromellosum | | Überzug | | Lactose Monohydrate | 0.252 mg | | | Macrogol | 6000 | | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 28 Comprimé(s) | 6.89 | 16.75 | B | LS | Non | | 002 | 98 Comprimé(s) | 22.22 | 40.60 | B | LS | Non |
|
|
